Program in Pancreas and Biliary Disorders

Click here to view a printable PDF of our Pancreas Program brochure.

PARTICIPATING PROVIDERS
Jason N. Rogart, MD, Director (Interventional Gastroenterologist & Therapeutic Endoscopist)
Christopher J. Gannon, MD, FACS (Surgeon)
Steven A. Johnson, MD, FACS (Surgeon)
Francis E. Rosato, MD, FACS (Surgeon)
Joshua Cantor, MD (Pathologist)

Program Description
Pancreatic and biliary disorders can be among the most challenging gastrointestinal conditions to diagnose and treat, and they are becoming more and more common. The good news is that using advanced diagnostic and therapeutic technologies and techniques, some of these conditions can be prevented and cured, while others can be successfully managed. The Program in Pancreas and Biliary Disorders at Capital Health offers a multi-disciplinary approach to optimize not only the care patients will receive, but also to better coordinate their care with referring physicians, medical oncologists, and other providers.

Our expert physicians have dedicated extra years to specialized training in these techniques and technologies, including advanced therapeutic gastrointestinal endoscopy, surgical oncology, and minimally invasive surgery.

Diseases/Conditions Treated

Pancreatic cancer
Pancreatic cysts
Pancreatic neuroendocrine tumors
Abdominal/back pain caused by pancreas or bile duct cancer
Acute Pancreatitis
Chronic Pancreatitis
Autoimmune Pancreatitis
Pancreatic pseudocyst
Cholangiocarcinoma (bile duct cancer)
Bile duct stones
Gallbladder stones
Bile duct strictures
Bile leaks
Cholangitis
…and more

State-Of-The-Art Endoscopic Technology and Treatments 

Advanced Surgical Treatments
Surgical intervention may be necessary to adequately treat many pancreatic and biliary disorders. In the past, this meant that the patient could routinely expect a long surgical incision, significant time in the hospital, and a protracted recovery time. Laparoscopic cholecystectomy was first performed in the United States in 1989. Since then, progressive advancement of minimally invasive techniques has been applied to an ever wider range of pancreato-biliary operations.

Whenever feasible, minimally invasive techniques are utilized to complete surgical therapies for the bile ducts and pancreas. These operations include laparoscopic cholecystectomy, laparoscopic distal pancreatectomy, and laparoscopic common bile duct exploration. These techniques have a track record of decreasing hospital stay and recovery time while maintaining the precision necessary when treating the bile ducts and pancreas.

In addition to minimally invasive techniques, advanced surgical techniques are utilized when a traditional open operation is required when treating a cancer. Cancers of the pancreas can be aggressive and require surgical resection as a major part of the curative treatment plan. As such, we utilize a combination of advanced energy devices, pylorus-preservation when appropriate, and a two-surgeon team to provide the best possible surgical care.

Clinical Research and Education
As part of the Center’s mission to improve patient care and remain on the cutting edge of technology, our physicians are continually involved in clinical research and education. All procedures, however, are performed only by the attending gastroenterologist or surgeon, without trainee involvement. Our gastroenterologists and surgeons are often among the first to trial new equipment before or right after it becomes commercially available, and they have published numerous studies in the most prestigious medical journals in gastroenterology and surgery, as well as published numerous book chapters.

Selected Publications

Dr. Jason Rogart
Rogart JN, Loren DE, Signu BS, Kowalski TE. Cyst Wall Puncture and Aspiration during EUS-guided Fine Needle Aspiration May Increase the Diagnostic Yield of Mucinous Cysts of the Pancreas.  Journal of Clinical Gastroenterology2011 Feb;45(2):164-9.
Rogart JN. The Plastic Biliary Stent: An Obsolete Device for Managing Pancreatic Cancer?  (editorial) Journal of Clinical Gastroenterology2010 Jul;44(6):389-90.
Rogart JN, Israel G, Jamidar P. Cystic duct stumpyemamanaged endoscopically. Clinical Gastroenterology &Hepatology2009 Aug;7(8):e43-4.
Rogart JN and Aslanian HR. Massive hemobilia after transjugular liver biopsy treated endoscopically and angiographically. Clinical Gastroenterology &Hepatology2008;6(12):A30.
Rogart JN, Boghos A, Rossi F, Al-Hashem H, Siddiqui UD, Jamidar P, Aslanian H. Analysis of endoscopic management of occluded metal biliary stents at a single tertiary care center. Gastrointestinal Endoscopy 2008;68(4):676-682.
Rogart JN and Loren DE. Balloon Sphincteroplasty and Post-Sphincterotomy Balloon Dilation. In: Monkemuller K, Miguel Muñoz-Navas, Mel Wilcox and Todd Baron, eds. Interventional Therapeutic Endoscopy (Karger Publishing, Basel, Switzerland, 2010)
Loren, DE, Kavanaugh B, Kowalski TE, Etemad B, and Rogart JN. Section X: Pancreas and Biliary Diseases. In: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Review and Assessment, 9th ed. DiMarino AJ, ed. (Saunders, 2010)
Niedenthal A, Dancygier H, Rogart J. EndoscopicUltrasonography (chapter 42). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Rogart J, Stenscheke F.Cholangioscopy (chapter 41). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Stenschke F, Dancygier H, Rogart J.  Endoscopic Retrograde and Percutaneous Transhepatic Cholangiography (chapter 40). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Dancygier H, Rogart J.  Evaluation of the patient with hepatobiliary disease: History (chapter 31). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Dancygier H, Rogart J.  Approach to the Patient with Cholestasis and Jaundice(chapter 52).In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Lee DS, Kwok K, Gannon C, and Rogart J.Busulfan-associated asymptomatic type I Mirizzi’s Syndrome.  American Journal of Gastroenterology 2010;105(S1):AB543;  Presentation at ACG Annual Meeting 2010, San Antonio.
Rogart JN, Orfanidis N, Korenblit J, Coben R, Infantolino A, Kowalski TE, loren DE. Incremental diagnostic yield of on-site quick-prep smear versus cell-block cytology in EUS-FNA of solid and cystic masses.American Journal of Gastroenterology 2009;104(S3):AB152;  Presentation at ACG Annual Meeting 2009, San Diego.

Dr. Christopher Gannon
August DA, Gannon CJ.Guest Editorial: Neoadjuvant therapy, predictors of response, and patient outcomes. Journal of Surgical Oncology 2010 Aug 1; 102(2): 135-40.
Gannon CJ ̧ August DA. Adjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma: Postoperative therapy is not the same as adjuvant therapy. American Journal of Hematology/Oncology April 2009.
Gannon CJ, Izzo F, Aloia TA, Pignata S, Nasti G, Vallone P, Orlando R, Scordino F, Curley SA. Can Hepatocellular Cancer Screening Increase the Proportion of Long-Term Survivors? Hepatogastroenterology. 2009 Jul-Aug;56(93):1152-6.
Gannon CJ, Mukherjee P, Patra C, Bhattacharya R, Curley SA. Intracellular Gold Nanoparticles Enhance Non-Invasive Radiofrequency Thermal Destruction of Human Gastrointestinal Cancer Cells. Journal of Nanobiotechnology, 2008 Jan; 6 (2):1-9.
Thomas MB, Tetzlaff E, Lozano R, Samp L, Butler CE, Gannon CJ, Hamilton S, Vauthey JN, Abdalla EK. Curing Hepatocellular Carcinomatosis with Biologic Therapy and Surgery: Achieving the Impossible? Journal of Surgical Oncology 2008; 97:82-84.
Gannon CJ, Curley SA. Hepatocellular Carcinoma: Anatomy and Staging. In: D. P. Kelsen, J. M. Daly, S. E. Kern, B. Levin, J. E. Tepper (eds). Gastrointestinal Oncology: Principles and Practice. 2nd Edition; Lippincott, Williams, & Wilkins, Philadelphia, 2007.
Gannon CJ, Zager JS, Chang GJ, Feig WB, Wood CG, Skibber JM, Rodriguez-Bigas MA. Pelvic Exenteration Affords Safe and Durable Treatment for Locally Advance Rectal Carcinoma.Annals of Surgical Oncology, 2007 Jun; 14(6):1870-7.
Gannon CJ, Cherukuri P, Yakobson BI, Cognet L, Kittrell C, Weisman RB, Kanzius JS, Smalley RE, Schmidt HK, Curley SA. Non-invasive Radiofrequency Thermal Destruction of Cancer Cells Using Carbon Nanotubes.Cancer,2007 Dec 15;110 (12):2654-65.
Gannon CJ, Curley SA. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.Seminars in Radiation Oncology. 2005 Oct; 15(4): 265-72.
Cunningham SC, Gannon CJ, Napolitano LM. Small-bowel diverticulosis. American Journal of Surgery. 2005 Jul; 190(1):37-8.
Gannon CJ, Engbrecht B, Napolitano LM, Bass BL. Gastric Remnant Carcinoma: Re- evaluation of Screening Endoscopy. Surgical Endoscopy 2001 Dec; 15 (12): 1488.
August DA, Gannon CJ.Guest Editorial: Neoadjuvant therapy, predictors of response, and patient outcomes. Journal of Surgical Oncology 2010 Aug 1; 102(2): 135-40.
Gannon CJ̧ August DA. Adjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma: Postoperative therapy is not the same as adjuvant therapy. American Journal of Hematology/Oncology April 2009.
Gannon CJ, Izzo F, Aloia TA, Pignata S, Nasti G, Vallone P, Orlando R, Scordino F, Curley SA. Can Hepatocellular Cancer Screening Increase the Proportion of Long-Term Survivors? Hepatogastroenterology. 2009 Jul-Aug;56(93):1152-6.
Gannon CJ, Mukherjee P, Patra C, Bhattacharya R, Curley SA. Intracellular Gold Nanoparticles Enhance Non-Invasive Radiofrequency Thermal Destruction of Human Gastrointestinal Cancer Cells. Journal of Nanobiotechnology, 2008 Jan; 6 (2):1-9.
Thomas MB, Tetzlaff E, Lozano R, Samp L, Butler CE, Gannon CJ, Hamilton S, Vauthey JN, Abdalla EK. Curing Hepatocellular Carcinomatosis with Biologic Therapy and Surgery: Achieving the Impossible? Journal of Surgical Oncology 2008; 97:82-84.
Gannon CJ, Curley SA. Hepatocellular Carcinoma: Anatomy and Staging. In: D. P. Kelsen, J. M. Daly, S. E. Kern, B. Levin, J. E. Tepper (eds). Gastrointestinal Oncology: Principles and Practice. 2nd Edition; Lippincott, Williams, & Wilkins, Philadelphia, 2007.
Gannon CJ, Zager JS, Chang GJ, Feig WB, Wood CG, Skibber JM, Rodriguez-Bigas MA. Pelvic Exenteration Affords Safe and Durable Treatment for Locally Advance Rectal Carcinoma.Annals of Surgical Oncology, 2007 Jun; 14(6):1870-7.
Gannon CJ, Cherukuri P, Yakobson BI, Cognet L, Kittrell C, Weisman RB, Kanzius JS, Smalley RE, Schmidt HK, Curley SA. Non-invasive Radiofrequency Thermal Destruction of Cancer Cells Using Carbon Nanotubes.Cancer,2007 Dec 15;110 (12):2654-65.
Gannon CJ, Curley SA. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.Seminars in Radiation Oncology. 2005 Oct; 15(4): 265-72.
Cunningham SC, Gannon CJ, Napolitano LM. Small-bowel diverticulosis. American Journal of Surgery. 2005 Jul; 190(1):37-8.
Gannon CJ, Engbrecht B, Napolitano LM, Bass BL. Gastric Remnant Carcinoma: Re- evaluation of Screening Endoscopy. Surgical Endoscopy 2001 Dec; 15 (12): 1488.

Back to top